These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1435505)

  • 1. Teniposide for acute lymphoblastic leukemia.
    Med Lett Drugs Ther; 1992 Nov; 34(883):105-6. PubMed ID: 1435505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allergic reactions to teniposide (VM-26) in children with neoplasms].
    Wysocki M; Nowaczyk-Michalak A; Pilecki O
    Wiad Lek; 1992 Feb; 45(3-4):91-3. PubMed ID: 1413803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teniposide granted marketing approval.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
    Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
    Rivera GK; Evans WE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
    Verdeguer A; Ruiz JG; Ferris J; Esquembre C; Tasso MJ; Fernandez JM; Prieto F; Castel V
    Med Pediatr Oncol; 1992; 20(1):48-52. PubMed ID: 1727211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
    Hayes FA; Abromowitch M; Green AA
    Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
    Petros WP; Rodman JH; Relling MV; Christensen M; Pui CH; Rivera GK; Evans WE
    Pharmacotherapy; 1992; 12(4):273-7. PubMed ID: 1518726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide and teniposide in the treatment of acute leukemia.
    Björkholm M
    Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
    Fang CQ; Tang YM; Li HF; Song H; Shi SW; Yang SL; Xu WQ
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):536-7. PubMed ID: 15324576
    [No Abstract]   [Full Text] [Related]  

  • 11. On the oncology front.
    Meyer C
    Am J Nurs; 1993 Mar; 93(3):63-4. PubMed ID: 8095122
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased teniposide clearance with concomitant anticonvulsant therapy.
    Baker DK; Relling MV; Pui CH; Christensen ML; Evans WE; Rodman JH
    J Clin Oncol; 1992 Feb; 10(2):311-5. PubMed ID: 1732431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
    Rodman JH; Sunderland M; Kavanagh RL; Ochs J; Yalowich J; Evans WE; Rivera GK
    Cancer Res; 1990 Jul; 50(14):4267-71. PubMed ID: 2194652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somnolence, hypotension, and metabolic acidosis following high-dose teniposide treatment in children with leukemia.
    McLeod HL; Baker DK; Pui CH; Rodman JH
    Cancer Chemother Pharmacol; 1991; 29(2):150-4. PubMed ID: 1760858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
    Evans WE; Rodman JH; Relling MV; Petros WP; Stewart CF; Pui CH; Rivera GK
    J Pharmacol Exp Ther; 1992 Jan; 260(1):71-7. PubMed ID: 1731053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
    Jeng MR; Feusner J
    Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreduction and prognosis in childhood acute lymphoblastic leukemia.
    Aricò M; Masera G
    J Clin Oncol; 1997 Mar; 15(3):1285. PubMed ID: 9060574
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
    Pui CH
    Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.